We can generate reliability data for new products being introduced to market, and existing products for which clients have limited validation data. This testing contributes to improving overall asset reliability and reducing operational downtime.
Within our facility, we have a purpose-built biopharma process-emulation test platform which can fully assess component reliability.
The platform can recreate site specific process conditions to emulate true to life performance and soiling conditions. The controlled simulated lab testing is repeatable, accurate, fully sensorized, and PLC controlled, providing for full asset performance evaluation.
SCRI-IS has used this methodology to extend elastomer lifetimes for a number of clients:
- Client A – Global (18x sites) – 50 to 250% ECO interval increases
- Client B – 100 to 150% ECO interval increases
- Client C – 100% ECO interval increase
- Client D – 50 to 200% ECO interval increases
- Client E – 100% ECO interval increase
Testimonials
Linked Case Study
Check out our latest observations and insights into where it’s all going.